Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206490 · ClinicalTrials.gov registry record · Phase 2
Trial of Naltrexone and Dextromethorphan for Gulf War Illness
A Phase 2 study, sponsored by East Carolina University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT02206490: Completed Phase 2 study, sponsored by East Carolina University.
NCT02206490 is a Phase 2 study that has completed, run by East Carolina University. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02206490, a Phase 2 study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Veterans of the 1991 Gulf War who developed Gulf War Illness are being studied. Treatments with FDA approved generic drugs are being administered to see if they help with the symptoms of Gulf War Illness, such as chronic fatigue; difficulty with memory, concentration, and thinking; widespread chronic pain; and autonimic dysfunction. Drugs to be tested are dextromethorphan and naltrexone.
Primary Outcome
Symptoms of Gulf War Illness will be scored by participants using a ten center meter scale. Scores will be collected at the end of 12 weeks/16 weeks/28weeks
Interventions
- DRUG Dextromethorphan
- DRUG naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
What the finished NCT02206490 record still lists
NCT02206490 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Dextromethorphan is the first listed.
NCT02206490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02206490 about?
NCT02206490 is a clinical study titled "Trial of Naltrexone and Dextromethorphan for Gulf War Illness". Veterans of the 1991 Gulf War who developed Gulf War Illness are being studied. Treatments with FDA approved generic drugs are being administered to see if they help with the symptoms of Gulf War Illness, such as chronic fatigue; difficulty with memory, concentration, and thinking; widespread chroni...
What is the current status of trial NCT02206490?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2012-01. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02206490?
The interventions under investigation include: Dextromethorphan (DRUG), naltrexone (DRUG).
Who is sponsoring clinical trial NCT02206490?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02206490's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia